Author(s):
M.L.N. Acharyulu, P.V.S.R. Mohana Rao, I. Siva Ramakoti, P.Jayarangarao
Email(s):
acharyulu@cutmap.ac.in
DOI:
10.5958/2349-2988.2020.00027.3 
Address:
M.L.N. Acharyulu1*, P.V.S.R. Mohana Rao2, I. Siva Ramakoti3, P.Jayarangarao4
1Associate Professor, Centurion University of Technology and Management, Andhra Pradesh-530017, India.
2Research Scholar, Department of Engineering Chemistry, A.U. College of Engineering (A), Visakhapatnam, Andhra Pradesh- 530017, India.
3Assistant Professor, Centurion University of Technology and Management, Parlakhimundi, Village Alluri Nagar, R. Sitapur, Odisha 761211, India.
4Assitant Professor, Baba Institute of Technology and Sciences, Visakhapatnam, Andhra Pradesh, India-530041.
*Corresponding Author
Published In:
Volume - 12,
Issue - 3,
Year - 2020
ABSTRACT:
Two simple and sensitive visible spectrophotometric methods (A and B) for the assay of Eletriptan Hydro Bromide (EHB) in pure and pharmaceutical formulations were developed. Method A is based on oxidation of the drug with oxidant Potassium permanganate, followed by the estimation of un reacted oxidant with Fast green FCF (FGFCF),at a ?max 622nm.Method-B depends on reduction of 1, 2 or 3 oxygen atoms from Molybdate by the acid hydrolysis products of paraxetine (catechol unit and formaldehyde) of the drug producing one or more of the possible reduced species which has a characteristic intense green colour measured at ?max 641nm against a reagent blank. The amount of EHB in both methods were obtained from the Beers-Lambert’s plot. Regression analysis of Beer-Lambert plots showed good correlation in the concentration ranges for method A, and B are (4-24) µg/ml,(10-60) µg/ml, correlation co-efficient are 0.9992,0.9968 respectively. The Sandell’s sensitivities are 1.3738 x 10-2 (1 mole cm-1) for both methods and molar absorptivity values 6.8549 x 105 and 1.2115 x 105(µg cm¬-2). The proposed methods are applied to commercially available formulations and the results are statistically compared with those obtained by the UV reference method and validated by recovery studies. These methods are applied successfully for the estimation of the Eletriptan Hydrobromide in the presence of other ingredients that are usually present in formulations. These methods offer the advantages of rapidity, simplicity and sensitivity and low cost without the need for expensive instrumentation and reagents.
Cite this article:
M.L.N. Acharyulu, P.V.S.R. Mohana Rao, I. Siva Ramakoti, P.Jayarangarao. Validation of FGFCF and Ammonium molybdate in visible Spectrophotometric Determination of Eletriptan Hydro Bromide. Research J. Science and Tech. 2020; 12(3):195-200. doi: 10.5958/2349-2988.2020.00027.3
Cite(Electronic):
M.L.N. Acharyulu, P.V.S.R. Mohana Rao, I. Siva Ramakoti, P.Jayarangarao. Validation of FGFCF and Ammonium molybdate in visible Spectrophotometric Determination of Eletriptan Hydro Bromide. Research J. Science and Tech. 2020; 12(3):195-200. doi: 10.5958/2349-2988.2020.00027.3 Available on: https://rjstonline.com/AbstractView.aspx?PID=2020-12-3-5
REFERENCES:
1. Snyder, L.R., Kirkland, J.J ., Introduction to Modern Liquid Chromatography, 2nd Ed., John Wiley and Sons, Inc., p.292.
2. Sean C Sweetman, Martindale, The complete drug reference, Pharmaceutical Press, London, Chicago, 34th edition 2005.
3. http://en.wikipedia.org/wiki/Eletriptan.
4. John Macor E and Martin Wythes J. Indole Derivates. U.S. Patent no. 5545644, 1996.
5. D. Suneetha and A. Lakshmana Rao Int. J. Chem Envir and Pharm Research. 2010, 1(2), 95-99.
6. Gadi Raju Ramalinga Raju, Raju V.K Vegesna and G S Prasad Indo American Journal Pharmaceutical Research. 2013, 3(9), 7299-7306.
7. Dheeravath Saida Naik, Kasani Ramadevi, Bhagawan .D Int. J. Engineer. Res and Applications. 2013, 3(6), 1-5.
8. Sirish Chandra S, T. Priyanka, Naga Sowjanya, A. Ajitha, Uma Maheswara Rao . Int. J of Pharm Res and Anal. 2014, 4(5), 344-347.
9. Venugopal. V, Ramu. G, Biksham Babu. A and Rambabu. C. Int. J. Pharm Tech. Res. 2012, 4(4), 1504-1507.
10. Ramzia I. El-Bagary, Nashwah G. Mohammed and Heba A. Nasr Analytical Chemistry Insights. 2012, 7; 13-21.
11. G. Mani Kumar, J.V. L.N. Seshagiri Rao, N. Jyothi Int. J. Inv. Pharm. Sci. 2013, 1(4), 397-403
12. N. Usha Rani, R. Sreenivasa Rao, K. Saraswathi, T.E.G.K. Murthy Novus International Journal of Analytical Innovations. 2012, 1(3),19-29.
13. Miraz Zrcevic, Biljana Jocic, Snezana Agatonovic-kustrin and Ljiljana Zvanoic J. Serb. Chem. Soc. 2006, 71(11), 1195-1205.
14. Jocia B, Zecevia M, Zivanovia L, Protia A, Jadranin M J Pharm Biomed Anal. 2009, 50; 622-629.
15. P. Sunitha, CH. Jhansirani, B. Kavitha, N. Sirisha and A. Pavan Int. J. Pharm. Chem and Bio. Sci. 2012, 2(4), 427-430.
16. Kumara Swamy G, JMR Kumar, JVLN Sheshagiri Rao, U Ashok Kumar, E Vinaya Snehalatha. Int. J. Chem and Anal. Sci. 2011, 2(8), 123-125.
17. N. Balaji, V.R. Ivaraman, Dr. P. Neeraja J of Appl.Chem.2013,3(4), 20-28.
18. A. Suneetha, R. Naga Pradeep and A. Pratyusha. Int. J of Pharma. and Chem. science. 2014, 3(1), 66-70.
19. Ramzia I. El-Bagary, Nashwah G. Mohammed and Heba A. Nasr J. Chem. Pharm. Res. 2011, 3(4), 340-314.
20. Weiss, David J, Saunders, Kenneth, Lunte, Craig E. Int. J of Res. Pharm. and Biomed. Sciences. Electrophoresis. 2001, 22(1), 59-65.
21. Pavan Kommavarapu, Arthanareeswari Maruthapillai, Kamarai Palanisamy. J of Taibah University for Science. 2015, 9(4), 586-593.
22. Kumara Swamy G, JMR Kumar, JVLN Sheshagiri Rao, U Ashok Kumar, E Vinaya Snehalatha, International Journal of Chemical and Analytical Science,2011,2(8),123-125
23. Annasaheb S. Gaikwad et al. Ijppr. Human, 2019; Vol. 15 (1): 1-9.
24. Venkata Mahesh R., Amith N.,Sireesha K., Balaji M., 2011,4(8)
25. Pavan Kumar Kothapuvari , Swati Rawat, Darna Bhikshapathi, Int. J. Pharm. Sci. Drug Res, 2015, 7(6),484-488
26. T Hemant Kumar et al. Indo American Journal of Pharmaceutical Research. 2018,8(12), 1344-1349